Literature DB >> 25919532

Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.

Nicolas Stettler1, Colleen M McKiernan1, Court Q Melin1, Oluwakayode O Adejoro1, Nancy B Walczak1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25919532     DOI： 10.1001/jama.2015.3075

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  22 in total

1.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

Review 2.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

Review 3.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

Review 4.  Reducing Health Care Disparities in Sickle Cell Disease: A Review.

Authors:  LaTasha Lee; Kim Smith-Whitley; Sonja Banks; Gary Puckrein
Journal:  Public Health Rep       Date:  2019-10-10       Impact factor: 2.792

5.  Characterization of opioid use in sickle cell disease.

Authors:  Jin Han; Jifang Zhou; Santosh L Saraf; Victor R Gordeuk; Gregory S Calip
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-08-16       Impact factor: 2.890

6.  Red blood cell transfusion therapy for sickle cell patients with frequent painful events.

Authors:  Lee M Hilliard; Varsha Kulkarni; Bisakha Sen; Cathy Caldwell; Christina Bemrich-Stolz; Thomas H Howard; Amanda Brandow; Emily Waite; Jeffrey D Lebensburger
Journal:  Pediatr Blood Cancer       Date:  2018-08-27       Impact factor: 3.167

7.  The Role of Patient-Physician Communication on the Use of Hydroxyurea in Adult Patients with Sickle Cell Disease.

Authors:  Sarah M Jabour; Sara Beachy; Shayna Coburn; Sophie Lanzkron; Michelle N Eakin
Journal:  J Racial Ethn Health Disparities       Date:  2019-08-13

Review 8.  Sickle cell disease and implementation science: A partnership to accelerate advances.

Authors:  Allison A King; Ana A Baumann
Journal:  Pediatr Blood Cancer       Date:  2017-05-28       Impact factor: 3.167

Review 9.  Hydroxyurea therapy for sickle cell anemia.

Authors:  Patrick T McGann; Russell E Ware
Journal:  Expert Opin Drug Saf       Date:  2015-09-14       Impact factor: 4.250

10.  Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle Cell Anemia.

Authors:  Lydia H Pecker; Sarah Kappa; Adam Greenfest; Deepika S Darbari; Robert Sheppard Nickel
Journal:  J Pediatr       Date:  2018-06-29       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.